Cargando…

Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis

BACKGROUND: Glioblastoma multiforme (GBM) owes an ominous prognosis: its mean overall survival is 14 months. The extent of surgical resection (ESR) highlights among factors in which an association has been found to a somewhat better prognosis. However, the association between greater ESR and prolong...

Descripción completa

Detalles Bibliográficos
Autores principales: Revilla-Pacheco, Francisco, Rodríguez-Salgado, Pamela, Barrera-Ramírez, Mónica, Morales-Ruiz, María Paula, Loyo-Varela, Mauro, Rubalcava-Ortega, Johnatan, Herrada-Pineda, Tenoch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238332/
https://www.ncbi.nlm.nih.gov/pubmed/34160432
http://dx.doi.org/10.1097/MD.0000000000026432
_version_ 1783714883452272640
author Revilla-Pacheco, Francisco
Rodríguez-Salgado, Pamela
Barrera-Ramírez, Mónica
Morales-Ruiz, María Paula
Loyo-Varela, Mauro
Rubalcava-Ortega, Johnatan
Herrada-Pineda, Tenoch
author_facet Revilla-Pacheco, Francisco
Rodríguez-Salgado, Pamela
Barrera-Ramírez, Mónica
Morales-Ruiz, María Paula
Loyo-Varela, Mauro
Rubalcava-Ortega, Johnatan
Herrada-Pineda, Tenoch
author_sort Revilla-Pacheco, Francisco
collection PubMed
description BACKGROUND: Glioblastoma multiforme (GBM) owes an ominous prognosis: its mean overall survival is 14 months. The extent of surgical resection (ESR) highlights among factors in which an association has been found to a somewhat better prognosis. However, the association between greater ESR and prolonged overall (OS) survival is not a constant finding nor a proven cause-and-effect phenomenon. To our objective is to establish the strength of association between ESR and OS in patients with GBM through a systematic review and meta-analysis. METHODS: In accordance with PRISMA-P recommendations, we conducted a systematic literature search; we included studies with adult patients who had undergone craniotomy for GBM. Our primary outcome is overall postoperative survival at 12 and 24 months. We reviewed 180 studies, excluded 158, and eliminated 8; 14 studies that suited our requirements were analyzed. RESULTS: The initial level of evidence of all studies is low, and it may be degraded to very low according to GRADE criteria because of design issues. The definition of different levels of the extent of resection is heterogeneous and poorly defined. We found a great amount of variation in the methodology of the operation and the adjuvant treatment protocol. The combined result for relative risk (RR) for OS for 12 months analysis is 1.25 [95% confidence interval (95% CI) 1.14–1.36, P < .01], absolute risk reduction (ARR) of 15.7% (95% CI 11.9–19.4), relative risk reduction (RRR) of 0.24 (95% CI 0.18–0.31), number needed to treat (NNT) 6; for 24-month analysis RR is 1.59 (95% CI 1.11–2.26, P < .01) ARR of 11.5% (95% CI 7.7–15.1), relative risk reduction (RRR) of 0.53 (95% CI 0.33–0.76), (NNT) 9. In each term analysis, the proportion of alive patients who underwent more extensive resection is significantly higher than those who underwent subtotal resection. CONCLUSION: Our results sustain a weak but statistically significant association between the ESR and OS in patients with GBM obtained from observational studies with a very low level of evidence according to GRADE criteria. As a consequence, any estimate of effect is very uncertain. Current information cannot sustain a cause-and-effect relationship between these variables.
format Online
Article
Text
id pubmed-8238332
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82383322021-07-06 Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis Revilla-Pacheco, Francisco Rodríguez-Salgado, Pamela Barrera-Ramírez, Mónica Morales-Ruiz, María Paula Loyo-Varela, Mauro Rubalcava-Ortega, Johnatan Herrada-Pineda, Tenoch Medicine (Baltimore) 5700 BACKGROUND: Glioblastoma multiforme (GBM) owes an ominous prognosis: its mean overall survival is 14 months. The extent of surgical resection (ESR) highlights among factors in which an association has been found to a somewhat better prognosis. However, the association between greater ESR and prolonged overall (OS) survival is not a constant finding nor a proven cause-and-effect phenomenon. To our objective is to establish the strength of association between ESR and OS in patients with GBM through a systematic review and meta-analysis. METHODS: In accordance with PRISMA-P recommendations, we conducted a systematic literature search; we included studies with adult patients who had undergone craniotomy for GBM. Our primary outcome is overall postoperative survival at 12 and 24 months. We reviewed 180 studies, excluded 158, and eliminated 8; 14 studies that suited our requirements were analyzed. RESULTS: The initial level of evidence of all studies is low, and it may be degraded to very low according to GRADE criteria because of design issues. The definition of different levels of the extent of resection is heterogeneous and poorly defined. We found a great amount of variation in the methodology of the operation and the adjuvant treatment protocol. The combined result for relative risk (RR) for OS for 12 months analysis is 1.25 [95% confidence interval (95% CI) 1.14–1.36, P < .01], absolute risk reduction (ARR) of 15.7% (95% CI 11.9–19.4), relative risk reduction (RRR) of 0.24 (95% CI 0.18–0.31), number needed to treat (NNT) 6; for 24-month analysis RR is 1.59 (95% CI 1.11–2.26, P < .01) ARR of 11.5% (95% CI 7.7–15.1), relative risk reduction (RRR) of 0.53 (95% CI 0.33–0.76), (NNT) 9. In each term analysis, the proportion of alive patients who underwent more extensive resection is significantly higher than those who underwent subtotal resection. CONCLUSION: Our results sustain a weak but statistically significant association between the ESR and OS in patients with GBM obtained from observational studies with a very low level of evidence according to GRADE criteria. As a consequence, any estimate of effect is very uncertain. Current information cannot sustain a cause-and-effect relationship between these variables. Lippincott Williams & Wilkins 2021-06-25 /pmc/articles/PMC8238332/ /pubmed/34160432 http://dx.doi.org/10.1097/MD.0000000000026432 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 5700
Revilla-Pacheco, Francisco
Rodríguez-Salgado, Pamela
Barrera-Ramírez, Mónica
Morales-Ruiz, María Paula
Loyo-Varela, Mauro
Rubalcava-Ortega, Johnatan
Herrada-Pineda, Tenoch
Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
title Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
title_full Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
title_fullStr Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
title_full_unstemmed Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
title_short Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
title_sort extent of resection and survival in patients with glioblastoma multiforme: systematic review and meta-analysis
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238332/
https://www.ncbi.nlm.nih.gov/pubmed/34160432
http://dx.doi.org/10.1097/MD.0000000000026432
work_keys_str_mv AT revillapachecofrancisco extentofresectionandsurvivalinpatientswithglioblastomamultiformesystematicreviewandmetaanalysis
AT rodriguezsalgadopamela extentofresectionandsurvivalinpatientswithglioblastomamultiformesystematicreviewandmetaanalysis
AT barreraramirezmonica extentofresectionandsurvivalinpatientswithglioblastomamultiformesystematicreviewandmetaanalysis
AT moralesruizmariapaula extentofresectionandsurvivalinpatientswithglioblastomamultiformesystematicreviewandmetaanalysis
AT loyovarelamauro extentofresectionandsurvivalinpatientswithglioblastomamultiformesystematicreviewandmetaanalysis
AT rubalcavaortegajohnatan extentofresectionandsurvivalinpatientswithglioblastomamultiformesystematicreviewandmetaanalysis
AT herradapinedatenoch extentofresectionandsurvivalinpatientswithglioblastomamultiformesystematicreviewandmetaanalysis